142 related articles for article (PubMed ID: 12495686)
1. Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus.
Nakamura T; Ushiyama C; Suzuki Y; Inoue T; Shoji H; Shimada N; Koide H
J Hosp Infect; 2003 Jan; 53(1):58-63. PubMed ID: 12495686
[TBL] [Abstract][Full Text] [Related]
2. Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis.
Nakamura T; Ushiyama C; Suzuki Y; Osada S; Inoue T; Shoji H; Hara M; Shimada N; Koide H
Nephron Clin Pract; 2003; 94(2):c33-9. PubMed ID: 12845235
[TBL] [Abstract][Full Text] [Related]
3. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
4. The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis.
Ronco C
Crit Care; 2005; 9(6):631-3. PubMed ID: 16356251
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
Taniguchi T; Sato K; Kurita A; Noda T; Okajima M
Minerva Anestesiol; 2013 Jul; 79(7):758-61. PubMed ID: 23635997
[TBL] [Abstract][Full Text] [Related]
7. Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis.
Ebihara I; Nakamura T; Shimada N; Shoji H; Koide H
Am J Kidney Dis; 1998 Dec; 32(6):953-61. PubMed ID: 9856510
[TBL] [Abstract][Full Text] [Related]
8. Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma.
Nakamura T; Ushiyama C; Suzuki Y; Shoji H; Shimada N; Koide H
ASAIO J; 2002; 48(3):244-8. PubMed ID: 12058997
[TBL] [Abstract][Full Text] [Related]
9. [A meta-analysis of the effects of direct hemoperfusion with polymyxin B-immobilized fiber on prognosis in severe sepsis].
Qiu XH; Liu SQ; Guo FM; Yang Y; Qiu HB
Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):316-21. PubMed ID: 21600152
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
[TBL] [Abstract][Full Text] [Related]
12. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
Ishizuka M; Terasaki A; Kubota K
J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
[TBL] [Abstract][Full Text] [Related]
14. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin b-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis.
Nakamura T; Ushiyama C; Suzuki S; Shoji H; Shimada N; Ebihara I; Koide H
Ren Fail; 2000 Mar; 22(2):225-34. PubMed ID: 10803767
[TBL] [Abstract][Full Text] [Related]
16. Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy.
Nakamura T; Kawagoe Y; Matsuda T; Ebihara I; Koide H
Blood Purif; 2003; 21(4-5):282-6. PubMed ID: 12944727
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
18. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
20. Removal of cytokine inducing substances by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma containing Staphylococcus aureus challenge.
Jaber BL; Barrett TW; Cendoroglo Neto M; Sundaram S; King AJ; Pereira BJ
ASAIO J; 1998; 44(1):48-53. PubMed ID: 9466501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
